SEC Form 4 research

Telix Pharmaceuticals Ltd insider transactions

Issuer	Telix Pharmaceuticals Ltd
Tickers	TLX
Reporting owners	10
Officers and directors	2
Last public filing	2026-09-14

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-09-14	2026-09-07	Smith Darren Charlton	P	2,071	$9.66	Not reported

Officers and directors in the directory

Behrenbruch Christian — 2 qualifying
Smith Darren Charlton — 1 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.